VF
TPST icon

Virtu Financial’s Tempest Therapeutics TPST Stock Holding History

Virtu Financial’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,316
Closed -$36K – 2038
2024
Q4 		$36K Buy
+3,316
New +$42.8K ﹤0.01% 1204
2024
Q3 		– Sell
-4,771
Closed -$136K – 1891
2024
Q2 		$136K Buy
4,771
+2,573
+117% +$111K 0.01% 786
2024
Q1 		$112K Buy
2,198
+899
+69% +$45.4K 0.01% 905
2023
Q4 		$74K Sell
1,299
-650
-33% -$30.8K 0.01% 1096
2023
Q3 		$8K Buy
+1,949
New +$18.7K ﹤0.01% 1126
2021
Q1 		– Sell
-158
Closed -$66K – 2024
2020
Q4 		$66K Buy
+158
New +$54.6K 0.01% 1170
2018
Q3 		– Sell
-8
Closed -$21K – 2194
2018
Q2 		$21K Sell
8
-35
-81% -$92.2K ﹤0.01% 1857
2018
Q1 		$103K Buy
+43
New +$129K 0.01% 1571
2017
Q4 		– Sell
-22
Closed -$92K – 3008
2017
Q3 		$92K Buy
+22
New +$94K ﹤0.01% 2103

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's TPST Position: Q1 2025 in Review

Virtu Financial sold out of Tempest Therapeutics (TPST) in Q1 2025, closing a stake of 3,316 shares — an estimated $36K sold.

Virtu Financial first reported a position in TPST in Q3 2017 and held it in 9 quarters. The position peaked at $136K in Q2 2024. 23 funds tracked by Wall St. Rank hold TPST as of Q1 2025.

  • Virtu Financial reported no remaining Tempest Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 3,316 Tempest Therapeutics shares in Q1 2025, an estimated $36K.
  • Virtu Financial first reported a position in Tempest Therapeutics in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's Tempest Therapeutics position peaked at $136K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.